| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. | CHIEF COMMERCIAL OFFICER | Common Stock | 808K | $340K | $0.42 | Mar 7, 2024 | Direct |
| Outlook Therapeutics, Inc. | CHIEF COMMERCIAL OFFICER | Stock Option (Right to Buy) | 25K | Mar 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics, Inc. | Mar 20, 2024 | 1 | $0 | 4 | Mar 22, 2024 | CHIEF COMMERCIAL OFFICER |
| OTLK | Outlook Therapeutics, Inc. | Mar 7, 2024 | 1 | $26.2K | 4 | Mar 11, 2024 | CHIEF COMMERCIAL OFFICER |
| OTLK | Outlook Therapeutics, Inc. | Apr 17, 2023 | 1 | $0 | 4 | Apr 19, 2023 | Chief Commercial Officer |
| OTLK | Outlook Therapeutics, Inc. | Jan 20, 2023 | 1 | -$296K | 4 | Jan 24, 2023 | Chief Commercial Officer |
| OTLK | Outlook Therapeutics, Inc. | Jan 17, 2023 | 3 | -$204K | 4 | Jan 19, 2023 | Chief Commercial Officer |
| OTLK | Outlook Therapeutics, Inc. | Mar 31, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Chief Commercial Officer |
| OTLK | Outlook Therapeutics, Inc. | Dec 21, 2021 | 1 | $0 | 4 | Dec 23, 2021 | Chief Commercial Officer |
| OTLK | Outlook Therapeutics, Inc. | Dec 3, 2021 | 1 | $47.2K | 4 | Dec 6, 2021 | Chief Commercial Officer |